ORIGINAL RESEARCH
Synergistic Utility of Brain Natriuretic Peptide and Left Ventricular Strain in Patients With Significant Aortic Stenosis Andrew Goodman, MD; Kenya Kusunose, MD, PhD; Zoran B. Popovic, MD, PhD; Roosha Parikh, MD; Tyler Barr; Joseph F. Sabik, MD; L. Leonardo Rodriguez, MD; Lars G. Svensson, MD, PhD; Brian P. Griffin, MD; Milind Y. Desai, MD
Background-—In aortic stenosis (AS), symptoms and left ventricular (LV) dysfunction represent a later disease state, and objective parameters that identify incipient LV dysfunction are needed. We sought to determine prognostic utility of brain natriuretic peptide (BNP) and left ventricular global longitudinal strain (LV-GLS) in patients with aortic valve area
Synergistic Utility of Brain Natriuretic Peptide and Left Ventricular Strain in Patients With Significant Aortic Stenosis Andrew Goodman, MD; Kenya Kusunose, MD, PhD; Zoran B. Popovic, MD, PhD; Roosha Parikh, MD; Tyler Barr; Joseph F. Sabik, MD; L. Leonardo Rodriguez, MD; Lars G. Svensson, MD, PhD; Brian P. Griffin, MD; Milind Y. Desai, MD
Background-—In aortic stenosis (AS), symptoms and left ventricular (LV) dysfunction represent a later disease state, and objective parameters that identify incipient LV dysfunction are needed. We sought to determine prognostic utility of brain natriuretic peptide (BNP) and left ventricular global longitudinal strain (LV-GLS) in patients with aortic valve area
